$25.990
+0.081 (+0.31%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
類似チャート分析による AKTS の予測・予想
Alphio's AKTS stock price prediction model matches the current Aktis Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $26.83 (-0.35%). The 1-week path is $26.26 (-2.47%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Aktis Oncology Inc 株は買うべき？
Aktis Oncology (AKTS) is a good buy right now due to its current price of $25.78, which is significantly lower than the analyst price target of $40 set by Raymond James, indicating a potential upside of 55%. Additionally, the stock has shown a positive momentum with a 5-day change of +7.10% and a 20-day change of +16.81%. The main risk is the negative net income reported at -24,144,000 USD for Q2 2026, which reflects ongoing financial challenges.
AKTS の株価は Tuesday に $25.99 で引け、その前に上昇 +0.31%
Aktis Oncology Inc (AKTS) last closed at $26.92, gaining +3.58%. These facts feed the 1-day and 1-week AKTS price prediction above.
アナリストのコンセンサス
Aktis Oncology Inc（AKTS）：買い 3、中立 0、売り 0。見通し：Strong Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
予想の要因
Aktis Oncology Inc（AKTS）の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
類似チャートパターン
直近の値動きが AKTS に最も近い銘柄を、類似度順に表示します。
AKTS の季節性分析
Historically the probability of a positive September return for AKTS is 13.04%. August offers the highest probability of a positive month at 46.51%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。